MC Leeuwarden Selects ClinicalKey
AMSTERDAM, January 28, 2013 /PRNewswire/ --
Hospital in the Netherlands provides 650 clinicians access to Elsevier's 'clinical insight engine,' which delivers the most current clinically relevant, evidence-based answers
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that MC Leeuwarden will provide its 650 clinicians with access to ClinicalKey, Elsevier's pioneering "clinical insight engine." MC Leeuwarden is part of a select group of hospitals in the Netherlands called the STZ (the association of tertiary medical teaching hospitals).
Under the terms of the agreement, MC Leeuwarden will have access to ClinicalKey the tool's content, which includes more than 900 textbooks, 500 top medical journals and 9,000 procedural videos, providing the most current clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals.
"Fast access to the most current up-to-date medical and scientific information is a vital element for clinician's in their daily workflow. We were really impressed with ClinicalKey and what it has to offer," said Jelle Prins, Dean of the MC Leeuwarden Academy. "Clinical excellence is a big priority for us, and we are confident that this tool can help us to get access to the core-information and that it will provide our professionals with the latest state-of-the-art functionality. The way in which ClinicalKey presents its information is of real added value to our clinicians and organization."
Launched in April 2012, ClinicalKey provides the most current clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals. Its clinical reference search engine is powered by Elsevier's Smart Content, tagged with EMMeT (Elsevier Merged Medical Taxonomy), which enables ClinicalKey to understand clinical terms and thus discover medical content that is the most relevant, plus find related content that would be missed by other search engines. Clinicians, professors and medical students are able to quickly move from topic overview to in-depth specialty information in order to meet every day clinical challenges.
"MC Leeuwarden is one of the progressive institutions in the Netherlands, and we are proud that it selected ClinicalKey for its clinical reference needs," said Sebastian Vos, Senior Vice President, e-Solutions, EMEA-LA, Health Science at Elsevier. "Our content is comprehensive, trusted and quick, and this will help MC Leeuwarden find the most accurate response to help advance their training and ultimately, improve patient care."
For more information about ClinicalKey, visit http://info.clinicalkey.com
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations
Mer från detta företag
Ten Reaxys® Ph.D. Prize Finalists Selected to Present at Symposium in Hong Kong
27 Aug, 2015, 17:47 CET
Elsevier Launches New App for Tablets: My Knovel ToGo
25 Aug, 2015, 14:55 CET
Elsevier's PharmaPendium® Bolsters UCL's Research in Drug Repurposing and Personalized Medicine
24 Aug, 2015, 16:14 CET
Skapa innehåll för din webbplats
Förbättra din webbplats eller blogg med PR Newswires skräddarsydda nyhetsflöden.
Kontakta PR Newswire
Skicka oss ett mail till email@example.com eller ring oss på +46 (0)8 1200 1300
Bli en PR Newswire kund
Begär mer information , se PR Newswire produkter & tjänster eller ring oss på +46 (0)8 1200 1300